Tairx, Inc.
Clinical trials sponsored by Tairx, Inc., explained in plain language.
-
New oral gel could offer gentler cancer treatment
Disease control Recruiting nowThis early-phase study tests a new oral gel called TRX-920 in 30 people with advanced solid tumors that no longer respond to standard treatments. The gel contains an active anti-cancer drug (SN38) and aims to shrink tumors with fewer side effects than current IV chemotherapy. The…
Phase: PHASE1 • Sponsor: TaiRx, Inc. • Aim: Disease control
Last updated May 26, 2026 04:48 UTC
-
New hope for liver cancer: triple therapy trial launches
Disease control Recruiting nowThis study tests a new combination of drugs and a procedure for people with liver cancer that cannot be cured by surgery. About 40 participants will receive an experimental pill (CVM-1118), an immunotherapy drug (sintilimab), and a targeted treatment called TACE that blocks the t…
Phase: PHASE2 • Sponsor: TaiRx, Inc. • Aim: Disease control
Last updated May 26, 2026 04:32 UTC
-
New hope for advanced liver cancer: drug duo tested in phase 2 trial
Disease control Recruiting nowThis study tests a new experimental drug called CVM-1118 combined with the immunotherapy nivolumab in people with advanced liver cancer that cannot be removed by surgery. About 95 adults will receive the combination to see if it shrinks tumors and how long any benefit lasts. The …
Phase: PHASE2 • Sponsor: TaiRx, Inc. • Aim: Disease control
Last updated May 20, 2026 11:54 UTC